ArticleDrugs - real world outcomes2026

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.

Dianne Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.